Literature DB >> 6726521

Hypopituitarism in association with postaxial polydactyly.

F L Culler, K L Jones.   

Abstract

We report four patients, three boys and one girl, with polydactyly and hypopituitarism. All patients had postaxial polydactyly and subnormal growth hormone responses to standard provocative stimuli. Three of these patients had a family history of polydactyly and few other abnormalities. The remaining patient had a major malformation syndrome including a CNS hamartomatous tumor and early death; this patient had no family history of polydactyly. We believe that the association of postaxial polydactyly with hypopituitarism and possible CNS hamartomatous tumors is an important clinical consideration in the evaluation of children with suspected growth hormone deficiency.

Entities:  

Mesh:

Year:  1984        PMID: 6726521     DOI: 10.1016/s0022-3476(84)80486-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Pallister-Hall syndrome and McKusick-Kaufmann syndrome: one entity?

Authors:  K M Unsinn; N Neu; A Krejci; A Posch; G Menardi; I Gassner
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

2.  Functional characterization of a heterozygous GLI2 missense mutation in patients with multiple pituitary hormone deficiency.

Authors:  G M C Flemming; J Klammt; G Ambler; Y Bao; W F Blum; C Cowell; K Donaghue; N Howard; A Kumar; J Sanchez; H Stobbe; R W Pfäffle
Journal:  J Clin Endocrinol Metab       Date:  2013-02-13       Impact factor: 5.958

3.  Mutations in TFAP2B and previously unimplicated genes of the BMP, Wnt, and Hedgehog pathways in syndromic craniosynostosis.

Authors:  Andrew T Timberlake; Sheng Chih Jin; Carol Nelson-Williams; Robin Wu; Charuta G Furey; Barira Islam; Shozeb Haider; Erin Loring; Amy Galm; Derek M Steinbacher; Dawid Larysz; David A Staffenberg; Roberto L Flores; Eduardo D Rodriguez; Titus J Boggon; John A Persing; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-10       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.